BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

Malignant mesothelioma (MMe) is a cancer with poor prognosis and resistance to standard treatments. Recent reports have highlighted the role of the BRCA1 associated protein 1 gene (BAP1) in the development of MMe. In this study, the chemosensitivity of human mesothelioma cell lines carrying BAP1 wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr, Demonacos, Constantinos, Giordano, Antonio, Krstic-Demonacos, Marija, Mutti, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359027/
https://www.ncbi.nlm.nih.gov/pubmed/30669483
http://dx.doi.org/10.3390/ijms20020429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359027/
https://www.ncbi.nlm.nih.gov/pubmed/30669483
http://dx.doi.org/10.3390/ijms20020429

Ejemplares similares